Amy McBride Wendell - 16 Dec 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/s/ Marc Began, attorney-in-fact for Amy McBride-Wendell
Issuer symbol
AXGN
Transactions as of
16 Dec 2025
Net transactions value
-$978,503
Form type
4
Filing time
17 Dec 2025, 16:25:23 UTC
Previous filing
20 Jun 2025
Next filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wendell Amy McBride Director C/O AXOGEN, INC. 13631 PROGRESS BLVD., SUITE 400, ALACHUA /s/ Marc Began, attorney-in-fact for Amy McBride-Wendell 17 Dec 2025 0001400568

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $44,750 +5,000 +5.3% $8.95 98,826 16 Dec 2025 Direct
transaction AXGN Common Stock Options Exercise $128,747 +20,436 +21% $6.30 119,262 16 Dec 2025 Direct
transaction AXGN Common Stock Options Exercise $128,466 +18,248 +15% $7.04 137,510 16 Dec 2025 Direct
transaction AXGN Common Stock Sale $146,560 -5,000 -3.6% $29.31 132,510 16 Dec 2025 Direct F1
transaction AXGN Common Stock Sale $599,020 -20,436 -15% $29.31 112,074 16 Dec 2025 Direct F1
transaction AXGN Common Stock Sale $534,885 -18,248 -16% $29.31 93,826 16 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Stock Option (right to purchase) Options Exercise $0 -5,000 -100% $0.000000 0 16 Dec 2025 Common Stock 5,000 $8.95 Direct F2
transaction AXGN Stock Option (right to purchase) Options Exercise $0 -20,436 -100% $0.000000 0 16 Dec 2025 Common Stock 20,436 $6.30 Direct F3
transaction AXGN Stock Option (right to purchase) Options Exercise $0 -18,248 -100% $0.000000 0 16 Dec 2025 Common Stock 18,248 $7.04 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Board of Directors' non-qualified stock option grant that vested in full May 26, 2017.
F3 Board of Directors' non-qualified stock option grant that vested in full September 1, 2024.
F4 Board of Directors' non-qualified stock option grant that vested in full June 6, 2025.